John Morser

发表

Exogenous activated protein C inhibits the progression of diabetic nephropathy

Y. Takei, M. Toda, E. Gabazza, 2012, Journal of thrombosis and haemostasis : JTH.

Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications.

I. Marzi, Y. Takei, E. Gabazza, 2013, Immunobiology.

Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy‐associated tubulointerstitial fibrosis

N. Bruno, Y. Takei, E. Gabazza, 2007, Journal of thrombosis and haemostasis : JTH.

FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834.

J. Morser, A. Johns, D. Light, 2001, Thrombosis research.

What has been learnt from the thrombin‐activatable fibrinolysis inhibitor‐deficient mouse?

John Morser, E. C. Gabazza, Lawrence L.K. Leung, 2010, Journal of thrombosis and haemostasis : JTH.

Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation.

J. Lin, E. Blasko, C. Glaser, 1992, The Journal of clinical investigation.

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) levels are decreased in patients with trauma-induced coagulopathy.

I. Marzi, Y. Takei, E. Gabazza, 2013, Thrombosis research.

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

P. Verhallen, M. Nagashima, J. Morser, 2000, Thrombosis research.

Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice

T. Nishimura, J. Higgins, J. Morser, 2018, Journal of thrombosis and haemostasis : JTH.

Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs

M. Nagashima, J. Morser, B. Martin-McNulty, 2003, Thrombosis and Haemostasis.